Insulin secretion studied in the perfused rat pancreas. II. Effect of glucose, glucagon, 3'5' adenosine monophosphate, theophylline, imidazole and phenoxybenzamine; their interaction with diazoxide.
D000227:Adenine Nucleotides / Q000494:pharmacology*; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D002021:Buffers; D000242:Cyclic AMP / Q000032:analysis / Q000037:antagonists & inhibitors / Q000494:pharmacology; D003981:Diazoxide / Q000032:analysis / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D005934:Glucagon / Q000032:analysis / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D005947:Glucose / Q000032:analysis / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D007093:Imidazoles / Q000032:analysis / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D008297:Male; D010179:Pancreas / Q000187:drug effects / Q000378:metabolism*; D010477:Perfusion; D010643:Phenoxybenzamine / Q000032:analysis / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D011863:Radioimmunoassay; D051381:Rats; D013268:Stimulation, Chemical; D013806:Theophylline / Q000032:analysis / Q000037:antagonists & inhibitors / Q000494:pharmacology*
D000227:Adenine Nucleotides; D000317:Adrenergic alpha-Antagonists; D002021:Buffers; D007093:Imidazoles; D007328:Insulin; D010643:Phenoxybenzamine; D005934:Glucagon; D013806:Theophylline; D000242:Cyclic AMP; D005947:Glucose; D003981:Diazoxide